Adma Biologics reported $237.88M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Adma Biologics USD 237.88M 457K Dec/2025
Alnylam Pharmaceuticals USD 133.44M 1.07M Mar/2026
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Novavax USD 162.58M 106K Dec/2025
Omeros USD 611K 17K Dec/2023
Takeda JPY 1.58B 241K Mar/2026